Isaac Y. Kim

miR-31-3p functions as a tumor suppressor by directly targeting GABBR2 in prostate cancer

Sujin Choi, Soonchul Lee, Young-hoon Han, 2022, Frontiers in Oncology.

Prostatic ductal system in rats: Tissue‐specific expression and regional variation in stromal distribution of transforming growth factor‐β1

Chung Lee, J. Nemeth, J. Sensibar, 1997, The Prostate.

Expression of estrogen receptors‐α and ‐β in bladder cancer cell lines and human bladder tumor tissue

G. Sonpavde, S. Lerner, Carolyn L. Smith, 2006 .

Preoperative plasma levels of transforming growth factor β1 strongly predict clinical outcome in patients with bladder carcinoma

M W Kattan, B Andrews, M. Kattan, 2001, Cancer.

Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3(1)‐TGF‐β type II dominant negative receptor

Jay H. Chang, R. Buttyan, L. Doglio, 2000, The Prostate.

Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy.

M. Kattan, T. Wheeler, S. Shariat, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates with tumor grade in human prostate cancer tissues.

H. Tokunaga, D. Jin, D. H. Lee, 2000, Cancer research.

Decreased expression of transforming growth factor beta receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients.

T. Wheeler, S. Lerner, H. Tokunaga, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Loss of expression of transforming growth factor beta type I and type II receptors correlates with tumor grade in human prostate cancer tissues.

K. Miyazono, J. Nemeth, H. Ahn, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.